F1000Research · 2020 · 293 citations · 87 references
Life SciencesImmunologyPathobiologyImmunopathologyInflammationMucosal ImmunologyGastrointestinal ImmunologyGastrointestinal InflammationGut MicrobiotaImmune-mediated Inflammatory DiseasesInflammatory Bowel DiseaseMucosal InflammationHost GeneticsImmune-mediated ColitisInflammatory Bowel Disease GeneticsInflammatory Bowel Disease ImmunopathogenesisInflammatory Bowel Disease PathogenesisInflammatory Bowel Disease PathologyInflammatory Bowel Disease PathophysiologyUlcerative Colitis Pathology
Inflammatory bowel diseases are common, complex, immune-mediated conditions with a sharply rising global prevalence. While major advances since 2000 have provided strong mechanistic clues implicating a de-regulation in the normal interaction among host genetics, immunity, microbiome, and the environment, more recent progress has generated entirely new hypotheses and also further refined older disease concepts. In this review, we focus specifically on these novel developments in the pathogenesis of ulcerative colitis.
87
A human gut microbial gene catalogue established by metagenomic sequencing
Junjie Qin, Ruiqiang Li, Jeroen Raes et al. · Nature · 2010 · 11.7K citations · Full text
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Dirk Gevers, Subra Kugathasan, Lee A. Denson et al. · Cell Host & Microbe · 2014 · 3.3K citations · Full text
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text